1 – 21 of 21
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons
(
- Contribution to journal › Article
- 2018
-
Mark
Chronic active arthritis driven by macrophages without involvement of T cells : A Novel Experimental Model of Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Streptococcal Endo-β-N-Acetylglucosaminidase Suppresses Antibody-Mediated Inflammation In Vivo
(
- Contribution to journal › Article
- 2015
-
Mark
System A amino acid transporters regulate glutamine uptake and attenuate antibody-mediated arthritis.
(
- Contribution to journal › Article
- 2013
-
Mark
Dominant suppression of inflammation by glycan-hydrolyzed IgG [Retracted]
(
- Contribution to journal › Article
- 2012
-
Mark
Cartilage oligomeric matrix protein specific antibodies are pathogenic
(
- Contribution to journal › Article
- 2011
-
Mark
Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development
(
- Contribution to journal › Article
- 2008
-
Mark
Therapeutic cleavage of IgG: new avenues for treating inflammation.
(
- Contribution to journal › Article
-
Mark
Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
(
- Contribution to journal › Article
- 2007
-
Mark
Blocking of experimental arthritis by cleavage of IgG antibodies in vivo
(
- Contribution to journal › Article
-
Mark
Monoclonal antibody production using a new supermacroporous cryogel bioreactor
(
- Contribution to journal › Article
-
Mark
Ethanol prevents development of destructive arthritis
(
- Contribution to journal › Article
- 2006
-
Mark
Arthritis induced with cartilage-specific antibodiesis IL-4-dependent.
(
- Contribution to journal › Article
-
Mark
Therapeutic Vaccination of Active Arthritis with a Glycosylated Collagen Type II Peptide in Complex with MHC Class II Molecules.
(
- Contribution to journal › Article
-
Mark
Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium
(
- Contribution to journal › Article
- 2005
-
Mark
A genetic contamination in MHC-congenic mouse strains reveals a locus on chromosome 10 that determines autoimmunity and arthritis susceptibility.
(
- Contribution to journal › Article
-
Mark
Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells
(
- Contribution to journal › Article
- 2003
-
Mark
Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
(
- Contribution to journal › Article
-
Mark
Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB.
(
- Contribution to journal › Article
- 2002
-
Mark
IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis.
(
- Contribution to journal › Article